Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Q32 Bio Inc. (QTTB)
- Autolus Therapeutics PLC Sponsored ADR AUTL 0.91 −7.14%
- Q32 Bio Inc. QTTB 8.34 −1.65%
Autolus Therapeutics PLC Sponsored ADR and Q32 Bio Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Q32 Bio Inc. are of similar size ($260.9M and $253.8M). Autolus Therapeutics PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 168.8% against −307.3%. Q32 Bio Inc. has the higher net margin (808.0% vs −186.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Q32 Bio Inc. leads on 14 and Autolus Therapeutics PLC Sponsored ADR on 1.
Valuation
Profitability
| Metric | AUTL | QTTB | Biotechnology median |
|---|---|---|---|
| Gross margin | 35.76% | 100.00% | 70.18% |
| Operating margin | (159.61%) | 725.53% | 0.00% |
| Net margin | (186.37%) | 808.04% | 0.00% |
| Free cash flow margin | (131.12%) | 280.89% | 0.00% |
| Return on equity | (174.92%) | 23.96% | (51.58%) |
| Return on assets | (43.23%) | 18.17% | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack